Author: Matcheri S. KeshavanPublisher: Taylor & Francis
ISBN: 9781138009950
Category :
Languages : en
Pages :
Book Description
First published in 1992. Routledge is an imprint of Taylor & Francis, an informa company.
Drug-Induced Dysfunction in Psychiatry
Author: Matcheri S. KeshavanPublisher: Taylor & Francis
ISBN: 9781138009950
Category :
Languages : en
Pages :
Book Description
First published in 1992. Routledge is an imprint of Taylor & Francis, an informa company.
Drug-induced Dysfunction in Psychiatry
Author: Matcheri S. KeshavanPublisher: Taylor & Francis
ISBN: 9780891169611
Category : Iatrogenic diseases
Languages : en
Pages : 396
Book Description
Discusses the general principles of therapeutics focusing on how to avoid or deal with adverse drug effects. It includes details on adverse neuropsychiatric effects of drugs used in psychiatry and also looks at non-neurological syndromes related to
Ending Discrimination Against People with Mental and Substance Use Disorders
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309439124
Category : Social Science
Languages : en
Pages : 171
Book Description
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
DSM-5 Classification
Author: American Psychiatric AssociationPublisher: American Psychiatric Publishing
ISBN: 9780890425664
Category : Mental illness
Languages : en
Pages : 0
Book Description
This handy DSM-5(R) Classification provides a ready reference to the DSM-5 classification of disorders, as well as the DSM-5 listings of ICD-9-CM and ICD-10-CM codes for all DSM-5 diagnoses. To be used in tandem with DSM-5(R) or the Desk Reference to the Diagnostic Criteria From DSM-5(R), the DSM-5(R) Classification makes accessing the proper diagnostic codes quick and convenient. With the advent of ICD-10-CM implementation in the United States on October 1, 2015, this resource provides quick access to the following: - The DSM-5(R) classification of disorders, presented in the same sequence as in DSM-5(R), with both ICD-9-CM and ICD-10-CM codes. All subtypes and specifiers for each DSM-5(R) disorder are included.- An alphabetical listing of all DSM-5 diagnoses with their associated ICD-9-CM and ICD-10-CM codes.- Separate numerical listings according to the ICD-9-CM codes and the ICD-10-CM codes for each DSM-5(R) diagnosis.- For all listings, any codable subtypes and specifiers are included with their corresponding ICD-9-CM or ICD-10-CM codes, if applicable. The easy-to-use format will prove indispensable to a diverse audience--for example, clinicians in a variety of fields, including psychiatry, primary care medicine, and psychology; coders working in medical centers and clinics; insurance companies processing benefit claims; individuals conducting utilization or quality assurance reviews of specific cases; and community mental health organizations at the state or county level.
Anxiety and Substance Use Disorders
Author: Sherry H. StewartPublisher: Springer Science & Business Media
ISBN: 0387742905
Category : Psychology
Languages : en
Pages : 280
Book Description
Disorders of anxiety and substance use are, for some reason, rarely treated in an integrated fashion by professionals. This timely volume addresses this glaring omission with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder, across a range of substances and of anxiety disorders, to give the reader comprehensive knowledge in a practical format.
Mental Disorders in Primary Care
Author: Andre F. CarvalhoPublisher: Oxford University Press
ISBN: 0198746636
Category : Medical
Languages : en
Pages : 385
Book Description
An invaluable guide to psychiatric presentation, diagnosis and treatment in a primary care setting.
Your Drug May Be Your Problem
Author: Peter Roger BregginPublisher: Da Capo Lifelong Books
ISBN:
Category : Family & Relationships
Languages : en
Pages : 296
Book Description
Provides uncensored descriptions of the dangers involved in taking every kind of psychiatric medication, and tells how to safely stop taking each type. Complex material is explained in plain language. Discusses the role of pharmaceutical companies in the psychiatric drug explosion, and considers ethical and scientific questions surrounding these drugs. Breggin is international director of the Center for the Study of Psychiatry and Psychology, and is the author of Talking Back to Prozac and Toxic Psychiatry. Cohen is a professor of social work at the University of Montreal, and is associate editor of The Journal of Mind and Behavior. Annotation copyrighted by Book News, Inc., Portland, OR
Brain-disabling Treatments in Psychiatry
Author: Peter Roger BregginPublisher:
ISBN:
Category : Medical
Languages : en
Pages : 326
Book Description
First Episode Psychosis
Author: Katherine J. AitchisonPublisher: CRC Press
ISBN: 9781853174353
Category : Medical
Languages : en
Pages : 152
Book Description
The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.
Drug Induced Movement Disorders
Author: Stewart FactorPublisher: John Wiley & Sons
ISBN: 140513755X
Category : Medical
Languages : en
Pages : 480
Book Description
The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.